Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Ramos

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Transplantation|August 27, 1995
Evaluation of living renal donors. The current practice of US transplant centersM J Bia, E L Ramos, G M Danovitch, et al.
Clinical Transplantation|June 1, 1995
Hypomagnesemia in renal transplant patients: improvement over time and association with hypertension and cyclosporine levelsE L Ramos, Y M Barri, P Kubilis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1989
Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantationC B Carpenter, R L Kirkman, M E Shapiro, et al.
Transplantation Proceedings|February 1, 1989
Early experience with anti-Tac in clinical renal transplantationR L Kirkman, M E Shapiro, C B Carpenter, et al.
Transplantation Proceedings|February 1, 1993
Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survivalR J Howard, W W Pfaff, M E Brunson, et al.
Transactions of the Association of American Physicians|January 1, 1989
In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenicE L Ramos, J E Leggat, E L Milford, et al.
Transplantation|September 1, 1989
Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibodyE L Ramos, E L Milford, R L Kirkman, et al.
Transplantation Proceedings|February 1, 1991
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantationR L Kirkman, M E Shapiro, C B Carpenter, et al.
Transplantation|January 1, 1991
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantationR L Kirkman, M E Shapiro, C B Carpenter, et al.
Transplantation Proceedings|February 1, 1996
Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathologyK Solez, H Benediktsson, T Cavallo, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Transplantation|August 27, 1995
Evaluation of living renal donors. The current practice of US transplant centersM J Bia, E L Ramos, G M Danovitch, et al.
Clinical Transplantation|June 1, 1995
Hypomagnesemia in renal transplant patients: improvement over time and association with hypertension and cyclosporine levelsE L Ramos, Y M Barri, P Kubilis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1989
Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantationC B Carpenter, R L Kirkman, M E Shapiro, et al.
Transplantation Proceedings|February 1, 1989
Early experience with anti-Tac in clinical renal transplantationR L Kirkman, M E Shapiro, C B Carpenter, et al.
Transplantation Proceedings|February 1, 1993
Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survivalR J Howard, W W Pfaff, M E Brunson, et al.
Transactions of the Association of American Physicians|January 1, 1989
In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenicE L Ramos, J E Leggat, E L Milford, et al.
Transplantation|September 1, 1989
Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibodyE L Ramos, E L Milford, R L Kirkman, et al.
Transplantation Proceedings|February 1, 1991
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantationR L Kirkman, M E Shapiro, C B Carpenter, et al.
Transplantation|January 1, 1991
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantationR L Kirkman, M E Shapiro, C B Carpenter, et al.
Transplantation Proceedings|February 1, 1996
Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathologyK Solez, H Benediktsson, T Cavallo, et al.
Pageof 3